HPV-specific immunotherapy (Inovio Pharmaceuticals investigational therapy)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HPV-specific immunotherapy (Inovio Pharmaceuticals investigational therapy), covering 2020-12-23 to 2020-12-23. Get the full timeline:
Most recent: Clinical Trial Update: Study of HPV Specific Immunotherapy in Participants With HPV Associated Head and Neck Squamous Cell Carcinoma [Phase 1, Phase 2]